|Articles|August 10, 2018

TransCelerate and BioCelerate Launch New Technology Platform

TransCelerate BioPharma Inc., and BioCelerate have come together to launch a new technology platform, DataCelerateTM, to enable R&D data sharing. DataCelerate will connect clean, converted clinical and preclinical information within One Data Lake Solution and is now accessible for the participating member companies of TransCelerate and BioCelerate.

Read the full release here.


Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.